摘要
Abstract
Objective To study the clinical effect of labetalol combined with magnesium sulfate in the treatment of pregnancy induced hypertension syndrome. Methods 100 patients with pregnancy induced hypertension syndrome treat-ed in our hospital from July 2011 to June 2013 were selected and randomly divided into the observation group and the control group,with 50 patients in each group.Magnesium sulfate was given to the control group,labetalol was added to the observation group on the basis of control group.The blood pressure changes,24-hour urine protein amount before and after treatment,delivery outcomes between the two groups were compared. Results The systolic pressure and dias-tolic pressure of both groups decreased significantly after treatment,compared with before treatment,the difference was significant (P<0.05);But after the treatment,the decreasing of systolic pressure and diastolic pressure in the observation group were more than those of the control group,with significant differences (P<0.05).The 24-hour urine protein of both groups decreased significantly after treatment,compared with before treatment,the difference was significant (P<0.05);Af-ter treatment,the urine protein amount of the observation group was lower than that of the control group (P<0.05).The incidence of postpartum hemorrhage in the observation group was lower than that of the control group,with significant difference (P<0.05).However,in terms of premature birth,neonatal intrauterine distress and neonatal birth weight,the two groups had no significant difference (P>0.05). Conclusion In the treatment of pregnancy induced hypertension syn-drome,labetalol shows accurate effects and can maintain blood pressure smoothly,relieve urine protein preferably and reduce postpartum complications.关键词
拉贝洛尔/硫酸镁/妊娠高血压综合征Key words
Labetalol/Magnesium sulfate/Pregnancy induced hypertension syndrome分类
医药卫生
